Expression of Human Frataxin Is Regulated by Transcription Factors SRF and TFAP2
Open Access
- 20 August 2010
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 5 (8) , e12286
Abstract
Friedreich ataxia is an autosomal recessive neurodegenerative disease caused by reduced expression levels of the frataxin gene (FXN) due to expansion of triplet nucleotide GAA repeats in the first intron of FXN. Augmentation of frataxin expression levels in affected Friedreich ataxia patient tissues might substantially slow disease progression. We utilized bioinformatic tools in conjunction with chromatin immunoprecipitation and electrophoretic mobility shift assays to identify transcription factors that influence transcription of the FXN gene. We found that the transcription factors SRF and TFAP2 bind directly to FXN promoter sequences. SRF and TFAP2 binding sequences in the FXN promoter enhanced transcription from luciferase constructs, while mutagenesis of the predicted SRF or TFAP2 binding sites significantly decreased FXN promoter activity. Further analysis demonstrated that robust SRF- and TFAP2-mediated transcriptional activity was dependent on a regulatory element, located immediately downstream of the first FXN exon. Finally, over-expression of either SRF or TFAP2 significantly increased frataxin mRNA and protein levels in HEK293 cells, and frataxin mRNA levels were also elevated in SH-SY5Y cells and in Friedreich ataxia patient lymphoblasts transfected with SRF or TFAP2. We identified two transcription factors, SRF and TFAP2, as well as an intronic element encompassing EGR3-like sequence, that work together to regulate expression of the FXN gene. By providing new mechanistic insights into the molecular factors influencing frataxin expression, our results should aid in the discovery of new therapeutic targets for the treatment of Friedreich ataxia.Keywords
This publication has 38 references indexed in Scilit:
- Transforming Growth Factor-β1 Up-Regulation of Human α 1 (I) Collagen Is Mediated by Sp1 and Smad2 Transacting FactorsDNA and Cell Biology, 2009
- Diagnosis and treatment of Friedreich ataxia: a European perspectiveNature Reviews Neurology, 2009
- Unique aspects of transcriptional regulation in neurons - nuances in NFkappaB and Sp1-related factorsJournal of Neuroinflammation, 2009
- Long intronic GAA•TTC repeats induce epigenetic changes and reporter gene silencing in a molecular model of Friedreich ataxiaNucleic Acids Research, 2008
- Influence of Friedreich Ataxia GAA Noncoding Repeat Expansions on Pre-mRNA ProcessingThe American Journal of Human Genetics, 2008
- Iron-dependent regulation of frataxin expression: implications for treatment of Friedreich ataxiaHuman Molecular Genetics, 2008
- HDAC Inhibitors Correct Frataxin Deficiency in a Friedreich Ataxia Mouse ModelPLOS ONE, 2008
- Repeat-induced epigenetic changes in intron 1 of the frataxin gene and its consequences in Friedreich ataxiaNucleic Acids Research, 2007
- Effects of Friedreich's ataxia (GAA)n{middle dot}(TTC)n repeats on RNA synthesis and stabilityNucleic Acids Research, 2007
- The use of antioxidants in Friedreich’s ataxia treatmentExpert Opinion on Investigational Drugs, 2003